Related Experiment Video
Updated: Jul 19, 2026
13:04
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
Published on: March 18, 2015
Autologous blood vessels engineered from peripheral blood sample.
1Department of General and Vascular Surgery, Klinikum Hannover Oststadt - Heidehaus Hannover, Germany. thomas.aper@t-online.de
Summary
Researchers engineered stable fibrin tubes lined with endothelial cells from a single donor's blood. This tissue-engineered vascular graft shows promise for future autologous applications, though further improvements are needed for arterial grafting.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Vascular Biology
Background:
- Small-diameter vascular grafts (< or =5mm) are crucial for treating vascular diseases.
- Achieving long-term patency and functionality in engineered grafts remains a significant challenge.
- Complete endothelial lining and full biocompatibility are essential for graft success.
Purpose of the Study:
- To develop a biocompatible vascular conduit using tissue engineering.
- To create a functional graft from a scaffold and endothelial progenitor cells (EPCs) from a single donor's blood.
- To assess the potential of autologous blood-derived components for vascular graft engineering.
Main Methods:
- Endothelial progenitor cells (EPCs) and fibrin were isolated from porcine peripheral blood.
- Fibrin tubes were fabricated and seeded with EPCs.
- The constructs were cultured and perfused in a bioreactor in vitro.
Main Results:
- Stable, 12-15 cm long fibrin tubes were successfully generated from 100ml of blood.
- The tubes were completely lined with an endothelium-like monolayer.
- The engineered grafts exhibited remarkable elasticity and burst strength up to 90 mmHg.
Conclusions:
- A stable, endothelium-lined vascular conduit was successfully engineered from autologous fibrin and EPCs.
- While current stability is insufficient for arterial grafting, the results are promising for future functional autologous vascular graft development.
- Further improvements may lead to patient-specific vascular grafts derived entirely from their own blood.
